loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of MolPort-000-883-091 NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 YS Life Science Co., Ltd. (1)

filter

01 Bromfenac Sodium Sesquihydrate (1)

filter

01 South Korea (1)

URL Supplier Web Content
Bromfenac Sodium Sesquihydrate
POWDER (1g/g)
BULK INGREDIENT
40016-004
2010-02-10
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 91714-94-2 / Bromfenac API manufacturers, exporters & distributors?

Bromfenac manufacturers, exporters & distributors 1

16

PharmaCompass offers a list of Bromfenac API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bromfenac manufacturer or Bromfenac supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bromfenac manufacturer or Bromfenac supplier.

PharmaCompass also assists you with knowing the Bromfenac API Price utilized in the formulation of products. Bromfenac API Price is not always fixed or binding as the Bromfenac Price is obtained through a variety of data sources. The Bromfenac Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Bromfenac

Synonyms

91714-94-2, 2-(2-amino-3-(4-bromobenzoyl)phenyl)acetic acid, Xibrom, Bromfenac [inn], Bromfenaco, Bromfenacum

Cas Number

91714-94-2

Unique Ingredient Identifier (UNII)

864P0921DW

About Bromfenac

Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory activities. Upon ophthalmic administration, bromfenac binds to and inhibits the activity of cyclooxygenase II (COX II), an enzyme which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins (PG). By inhibiting PG formation, bromfenac is able to inhibit PG-induced inflammation, thereby preventing vasodilation, leukocytosis, disruption of the blood-aqueous humor barrier, an increase in vascular permeability and an increase in intraocular pressure (IOP).

MolPort-000-883-091 Manufacturers

A MolPort-000-883-091 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-000-883-091, including repackagers and relabelers. The FDA regulates MolPort-000-883-091 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-000-883-091 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MolPort-000-883-091 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

MolPort-000-883-091 Suppliers

A MolPort-000-883-091 supplier is an individual or a company that provides MolPort-000-883-091 active pharmaceutical ingredient (API) or MolPort-000-883-091 finished formulations upon request. The MolPort-000-883-091 suppliers may include MolPort-000-883-091 API manufacturers, exporters, distributors and traders.

click here to find a list of MolPort-000-883-091 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

MolPort-000-883-091 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MolPort-000-883-091 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for MolPort-000-883-091 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture MolPort-000-883-091 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain MolPort-000-883-091 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MolPort-000-883-091 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of MolPort-000-883-091 suppliers with NDC on PharmaCompass.

MolPort-000-883-091 Manufacturers | Traders | Suppliers

MolPort-000-883-091 Manufacturers, Traders, Suppliers 1
63

We have 1 companies offering MolPort-000-883-091

Get in contact with the supplier of your choice:

  1. Yonsung Fine Chemicals
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY